The increased activation contributes to the already elevated level of active kinases present in breast cancer cells, as Src activity ranges 4-30 fold higher than that observed in normal cells [68] and abundant ERK1/2 phosphorylation is present in 65% of tumors [69,70]. This evidence concerns the gene MAPK3 and breast cancer.